Foghorn Therapeutics, Inc. (FHTX)
5.29
+0.43
(+8.85%)
USD |
NASDAQ |
Apr 17, 16:00
5.27
-0.02
(-0.38%)
After-Hours: 20:00
Foghorn Therapeutics Total Liabilities (Quarterly) : 503.16M for Dec. 31, 2025
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Eli Lilly & Co. | 85.94B |
| Halozyme Therapeutics, Inc. | 2.665B |
| Vertex Pharmaceuticals, Inc. | 7.477B |
| Verastem, Inc. | 189.24M |
| Fortress Biotech, Inc. | 123.36M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 394.66M |
| Shareholders Equity (Quarterly) | -108.50M |
| Debt to Equity Ratio | -0.3804 |
| Current Ratio | 2.732 |
| Net Debt Paydown Yield | -0.14% |